Federation Des Caisses Desjardins Du Quebec Myriad Genetics Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 30, 2024	SELL	$10.69 - $16.49 $1.25 Million - $1.92 Million	-116,609 Closed	0 $0
Q1 2020 Aug 30, 2024	SELL	$9.78 - $29.53 $678,389 - $2.05 Million	-69,365 Reduced 37.3%	116,609 $1.69 Billion
Q4 2019 Aug 30, 2024	BUY	$20.93 - $35.1 $565,130 - $947,735	27,001 Added 16.98%	185,974 $5.06 Billion
Q3 2019 Aug 30, 2024	SELL	$22.08 - $47.08 $58,357 - $124,432	-2,643 Reduced 1.64%	158,973 $4.55 Billion
Q2 2019 Aug 30, 2024	BUY	$22.67 - $35.0 $224,999 - $347,375	9,925 Added 6.54%	161,616 $4.48 Billion
Q1 2019 Aug 30, 2024	SELL	$26.93 - $34.7 $684,156 - $881,553	-25,405 Reduced 14.35%	151,691 $5.04 Billion
Q4 2018 Aug 30, 2024	BUY	$27.23 - $45.56 $4.82 Million - $8.07 Million	177,096 New	177,096 $5.15 Billion
Q3 2018 Aug 30, 2024	SELL	$37.57 - $50.34 $12,322 - $16,511	-328 Reduced 0.18%	177,096 $8.16 Billion
Q2 2018 Aug 30, 2024	BUY	$27.75 - $40.17 $727,494 - $1.05 Million	26,216 Added 17.34%	177,424 $6.64 Billion
Q1 2018 Aug 30, 2024	BUY	$28.83 - $41.01 $234,359 - $333,370	8,129 Added 5.68%	151,208 $4.47 Billion
Q4 2017 Aug 30, 2024	BUY	$28.45 - $37.14 $747,381 - $975,667	26,270 Added 22.49%	143,079 $4.9 Billion
Q2 2017 Aug 30, 2024	SELL	N/A	-23,678 Reduced 16.85%	116,809 $3.02 Billion
Q1 2017 Aug 30, 2024	BUY	N/A	140,487	140,487 $2.7 Billion

Others Institutions Holding MYGN

# of Institutions

254

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$247 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$168 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$109 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$84.2 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$76.5 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.31B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account